Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

Elemento

Click for External Resource*

https://www.nejm.org/doi/full/10.1056/NEJMc2025179

Click to read full article*

https://www.nejm.org/doi/full/10.1056/NEJMc2025179

The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.

Item Type

Publicación

Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.

Share this page:

Facebook Twitter e-mail

Was this resource helpful?

Título

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

Materia

Research

Descripción

A recent article suggested the rapid decay of anti–SARS-CoV-2 IgG in early infection, but the rate was not described in detail. We evaluated persons who had recovered from Covid-19 and referred themselves to our institution for observational research.

Autor

Ibarrondo, F. Javier, Jennifer A. Fulcher, David Goodman-Meza, Julie Elliott, Christian Hofmann, Mary A. Hausner, Kathie G. Ferbas, Nicole H. Tobin, Grace M. Aldrovandi, and Otto O. Yang.

Fecha

2020-07-21

Tipo

Publication

Citación

Ibarrondo, F. Javier, Jennifer A. Fulcher, David Goodman-Meza, Julie Elliott, Christian Hofmann, Mary A. Hausner, Kathie G. Ferbas, Nicole H. Tobin, Grace M. Aldrovandi, and Otto O. Yang. 2020. "Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19." New England Journal of Medicine.